The impact of recent next generation sequencing and the need for a new classification in gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of recent next generation sequencing and the need for a new classification in gastric cancer
Authors
Keywords
Gastric cancer, NGS, Biomarkers, Classificatory systems, Molecular pathology
Journal
Best Practice & Research Clinical Gastroenterology
Volume -, Issue -, Pages 101730
Publisher
Elsevier BV
Online
2021-02-16
DOI
10.1016/j.bpg.2021.101730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials
- (2021) F. Pietrantonio et al. ESMO Open
- Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
- (2020) Shota Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Hereditary diffuse gastric cancer: updated clinical practice guidelines
- (2020) Vanessa R Blair et al. LANCET ONCOLOGY
- Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to Date
- (2020) Megan Wheelden et al. OncoTargets and Therapy
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
- (2020) Matthew H. Bailey et al. Nature Communications
- EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
- (2020) Elizabeth C Smyth et al. GUT
- Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
- (2019) Irene Coati et al. BRITISH JOURNAL OF CANCER
- Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes
- (2019) Takafumi Oga et al. CANCER SCIENCE
- Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
- (2019) Megan Greally et al. CLINICAL CANCER RESEARCH
- Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
- (2019) Hui Cai et al. Journal of Translational Medicine
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
- (2019) Steven B. Maron et al. CLINICAL CANCER RESEARCH
- ctDNA in Gastric and Gastroesophageal Cancer: Prognostic, Predictive, or Preliminary?
- (2019) Alexander M. Frankell et al. CLINICAL CANCER RESEARCH
- Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
- (2019) Antonio Pellino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
- (2018) S T Kim et al. ANNALS OF ONCOLOGY
- Molecular Diagnostics in Pathology: Time for a Next-Generation Pathologist?
- (2018) Matteo Fassan ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study
- (2018) Manish A. Shah et al. CLINICAL CANCER RESEARCH
- A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
- (2018) Ugur Sahin et al. EUROPEAN JOURNAL OF CANCER
- Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
- (2018) Takeru Wakatsuki et al. JOURNAL OF GASTROENTEROLOGY
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma
- (2018) Steven B. Maron et al. Cancer Discovery
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma
- (2018) C. Mariette et al. Gastric Cancer
- 660PSafety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies
- (2018) S J Klempner et al. ANNALS OF ONCOLOGY
- Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- (2018) Shumei Kato et al. CLINICAL CANCER RESEARCH
- Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
- (2018) Shusuke Yagi et al. Gastric Cancer
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
- (2017) Angela N. Bartley et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
- (2017) Prabhsimranjot Singh et al. Journal of Hematology & Oncology
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Yung-Jue Bang et al. LANCET ONCOLOGY
- Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Daniel V T Catenacci et al. LANCET ONCOLOGY
- Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
- (2017) Eva-Maria Birkman et al. VIRCHOWS ARCHIV
- Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
- (2017) Yelena Y. Janjigian et al. Cancer Discovery
- Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
- (2017) Eirini Pectasides et al. Cancer Discovery
- Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer
- (2017) Kohei Shitara et al. Oncotarget
- Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma
- (2017) Manish A. Shah et al. JAMA Oncology
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival
- (2017) Elizabeth C. Smyth et al. JAMA Oncology
- Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
- (2016) H. H. Yoon et al. ANNALS OF ONCOLOGY
- Stromal-Based Signatures for the Classification of Gastric Cancer
- (2016) M. T. Uhlik et al. CANCER RESEARCH
- Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer
- (2016) Philip D. Dunne et al. CLINICAL CANCER RESEARCH
- Epigenetic inactivation of FAT4 contributes to gastric field cancerization
- (2016) Satoshi Yoshida et al. Gastric Cancer
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2016) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
- (2016) Nick Pavlakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
- (2016) Federica Grillo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Next-generation sequencing: advances and applications in cancer diagnosis
- (2016) Simona Serratì et al. OncoTargets and Therapy
- Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis
- (2016) E. Bria et al. Scientific Reports
- Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer
- (2015) Y. Kuboki et al. ANNALS OF ONCOLOGY
- Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
- (2015) Phillip Stahl et al. BMC GASTROENTEROLOGY
- Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal stromal tumors
- (2015) H Singh et al. INDIAN JOURNAL OF CANCER
- Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
- (2015) Yung-Jue Bang et al. JOURNAL OF CLINICAL ONCOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal stromal tumors
- (2015) H Singh et al. INDIAN JOURNAL OF CANCER
- EBV-Infection in Cardiac and Non-Cardiac Gastric Adenocarcinomas is Associated with Promoter Methylation ofp16,p14andAPC, but nothMLH1
- (2015) Helene Geddert et al. Analytical Cellular Pathology
- FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
- (2014) X Su et al. BRITISH JOURNAL OF CANCER
- HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
- (2014) Eric Van Cutsem et al. Gastric Cancer
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Causes and consequences of microsatellite instability in gastric carcinogenesis
- (2014) Sérgia Velho WORLD JOURNAL OF GASTROENTEROLOGY
- What is next generation sequencing?
- (2013) Sam Behjati et al. Archives of Disease in Childhood-Education and Practice Edition
- Gene methylation in gastric cancer
- (2013) Yiping Qu et al. CLINICA CHIMICA ACTA
- FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
- (2013) L. Xie et al. CLINICAL CANCER RESEARCH
- Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
- (2013) Florian Lordick et al. Gastric Cancer
- High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers
- (2013) Matteo Fassan et al. Gastric Cancer
- Gastric Signet Ring Cell Carcinoma: How to Investigate Its Impact on Survival
- (2013) Guillaume Piessen et al. JOURNAL OF CLINICAL ONCOLOGY
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer
- (2013) Kyong-Hwa Jun et al. International Journal of Surgery
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- FGFR2 gene amplification and clinicopathological features in gastric cancer
- (2012) K Matsumoto et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of Signet Ring Gastric Cancer
- (2012) Sharven Taghavi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis
- (2012) Nur Sabrina Sapari et al. PLoS One
- Silencing of Glutathione Peroxidase 3 through DNA Hypermethylation Is Associated with Lymph Node Metastasis in Gastric Carcinomas
- (2012) Dun-Fa Peng et al. PLoS One
- Gastric Cancer: Nagoya Is Not New York
- (2011) John S. Macdonald JOURNAL OF CLINICAL ONCOLOGY
- Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer
- (2011) Kaixiong Tao et al. MEDICAL ONCOLOGY
- Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux
- (2010) J. H. Rubenstein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
- (2010) William F. Anderson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation
- (2009) Guillaume Piessen et al. ANNALS OF SURGERY
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now